United States securities and exchange commission logo





                             August 1, 2022

       Mingfei Liu
       Chief Operating Officer
       U-BX Technology Ltd.
       Zhongguan Science and Technology Park
       No. 1 Linkong Er Road, Shunyi District, Beijing
       People   s Republic of China

                                                        Re: U-BX Technology
Ltd.
                                                            Amendment No. 5 to
Registration Statement on Form F-1
                                                            Filed July 19, 2022
                                                            File No. 333-262412

       Dear Mr. Liu:

             We have reviewed your amended registration statement and have the
following
       comments. In some of our comments, we may ask you to provide us with
information so we
       may better understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.
Unless we note
       otherwise, our references to prior comments are to comments in our July
14, 2022 letter.

       Amendment No. 5 to Registration Statement on Form F-1 filed on July 19,
2022

       General

   1.                                                   We note you revised the
expected offering price of your ordinary shares to be between
                                                        $4.00 and $5.00. Please
use the midpoint of this range in your prospectus where you
                                                        provide disclosure
based on the assumed initial public offering price. For example, revise
                                                        your use of proceeds,
capitalization, dilution, and underwriting information accordingly.
 Mingfei Liu
FirstName  LastNameMingfei Liu
U-BX Technology   Ltd.
Comapany
August     NameU-BX Technology Ltd.
       1, 2022
August
Page 2 1, 2022 Page 2
FirstName LastName
2.       We note your disclosure on page 109 that you "have 14 shareholders of
record, none of
         which is located in the United States." In Item 7 you refer to an
issuance "to all fourteen
         existing shareholders and two new investors." Please advise if you now
have 16
         shareholders of record and, if so, revise your disclosure accordingly.
Risk Factors
Our Ordinary Shares may be prohibited from being traded on a national exchange
under the
Holding Foreign Companies Accountable Act. . . , page 39

3.       We note that your auditor conducted their work with the collaboration
of its China-based
         offices. Please revise your risk factor disclosure to clarify whether
Article 177 of the PRC
         Securities Law means that the audit work papers of your financial
statements may not be
         fully inspected by the PCAOB without the approval of the PRC
authorities. Advise
         whether your common stock could be delisted and prohibited from being
traded over-the-
         counter under the HFCA Act if it is determined in the future that your
auditor, which has a
         presence in China, is unable to be fully inspected or investigated.
Lock-up Agreements, page 132

4.       We note that you filed the forms of Underwriting Agreement and Lock-up
Agreement as
         Exhibits 1.1 and 10.7, respectively, which contain certain exceptions
to the lock-up
         provisions with you and your directors and officers. Please disclose
these exceptions in
         your prospectus.
       You may contact Morgan Youngwood, Senior Staff Accountant, at (202)
551-3479 or
Stephen Krikorian, Accounting Branch Chief, at (202) 551-3488 if you have
questions regarding
comments on the financial statements and related matters. Please contact
Patrick Faller, Staff
Attorney, at (202) 551-4438 or Matthew Crispino, Staff Attorney, at (202)
551-3456 with any
other questions.



                                                               Sincerely,

                                                               Division of
Corporation Finance
                                                               Office of
Technology
cc:      William S. Rosenstadt